医学
败血症
氢化可的松
置信区间
内科学
队列
重症监护
队列研究
儿科
观察研究
临床试验
感染性休克
重症监护医学
休克(循环)
急诊医学
倾向得分匹配
耐火材料(行星科学)
疾病严重程度
生存分析
风险因素
随机对照试验
风险评估
优势比
作者
Lazaro Nelson Sanchez-Pinto,Robinder G. Khemani,Ngoc Duong,Mihir R. Atreya,Melania M. Bembea,Peter DeWitt,Idris V. R. Evans,Reid W. D. Farris,Edward Vincent S. Faustino,Alon Geva,Mark Hall,Christopher M. Horvat,Colin M. Rogerson,Seth Russell,Sareen Shah,Robert Scott Watson,Scott L. Weiss,Lucia C. Petito,Tellen D. Bennett
标识
DOI:10.1186/s13054-026-06430-x
摘要
Prognostic and predictive enrichment strategies could be used to address the heterogeneity of pediatric sepsis and identify subgroups of patients most likely to benefit from targeted therapies. Our aim was to determine if the use of the Phoenix Sepsis Score (PSS) can identify critically ill children with community-acquired sepsis who are most likely to benefit from early hydrocortisone therapy. This was an observational cohort study and target trial emulation in 15 pediatric intensive care units (PICUs) in the United States, including a development cohort and replication in a validation cohort. Patients < 18 years of age admitted to a PICU with confirmed or suspected community-acquired infection between 2010 and 2019 were included. Patients who were treated with systemic stress dose hydrocortisone in the first 24 h of PICU admission were compared with untreated patients across risk groups. There were 48,345 patients included in the main analysis. A PSS ≥ 4 points in the first 12 h of PICU admission had the best discrimination of outcomes, with a 10-fold higher mortality than those with a PSS < 4 in both the development and the validation cohorts. In the target trial emulation analysis, after adjusting for covariates associated with hydrocortisone use (age, malignancy, severity of illness, refractory shock status, and hospital), patients who received early hydrocortisone and were in the high-risk phenotype (PSS ≥ 4 in first 12 h) had a lower risk of in-hospital mortality (adjusted risk ratio [aRR] 0.72 [95% confidence interval [CI] 0.65–0.80]), while low-risk patients had increased risk (aRR 1.90 [95%CI 1.66–2.16], interaction p-value < 0.001) in the development cohort. The results were replicated in the validation cohort (aRR 0.79 [95%CI 0.68, 0.92] vs. aRR 2.95 [95%CI 2.43, 3.59], interaction p-value < 0.001). A highly generalizable risk stratification strategy using the easy-to-calculate PSS can be used for both prognostic and predictive enrichment in critically ill children with community-acquired sepsis. Further external and prospective validation of our results is warranted. Not applicable.
科研通智能强力驱动
Strongly Powered by AbleSci AI